期刊文献+

骨巨细胞瘤中骨保护因子及破骨细胞分化因子的表达 被引量:3

Gene expression of osteoprotegerin and osteoclast differentiation factor in giant cell tumor
原文传递
导出
摘要 目的 检测骨巨细胞瘤中骨保护因子 (OPG)及破骨细胞分化因子 (ODF)mRNA的表达 ,并探讨多核巨细胞的来源及造成骨吸收的分子机制。方法 采用半定量逆转录 聚合酶链反应(RT PCR)方法检测骨巨细胞瘤和正常骨组织中OPG、ODF及其辅助因子巨噬细胞克隆刺激因子、信号受体RANKmRNA的表达 ,并将两种组织中各因子的表达情况进行半定量比较。结果 正常骨组织中OPG、巨噬细胞克隆刺激因子、RANKmRNA有表达 ,ODF呈微弱表达 ;骨巨细胞瘤中OPG、ODF、巨噬细胞克隆刺激因子、RANKmRNA均有表达 ,ODF的表达非常丰富。骨巨细胞瘤中ODF与OPG的比值远远高于正常骨组织。结论 骨巨细胞瘤中的微环境具备破骨细胞形成及其促进骨吸收的必要条件 ,多核巨细胞的来源及其骨吸收功能与上述几种因子的表达有关。 Objective To investigate the gene expression of osteoprotegerin (OPG) and osteoclast differentiation factor (ODF/TRANCE/RANKL), two new members of the TNF-receptor superfamily, in giant cell tumor (GCT); to discuss the molecular mechanism of extensive bone resorption caused by GCT. Methods Using TRIzol reagent to prepare total RNA from GCT sample and normal bone tissue. By a first-strand complementary DNA (cDNA) synthesis kit, cDNA was synthesized from 2.0 μg RNA according to the manufacturer′s instructions. cDNA was then amplified by PCR . Amplification products were resolved by electrophoresis on a 1.5% agarose gel and stained with EB. The relative quantity of the PCR products were determined and the mRNA levels of OPG, ODF, M-CSF (cofactor of ODF), and RANK (receptor of ODF) were compared with that of the normal bone. Results GCT contained highly expressed mRNA of ODF , OPG, M-CSF and RANK. There was mRNA expression of OPG , M-CSF and RANK and less expression of ODF in normal bone. The ODF mRNA and RANK mRNA in GCT were more abundant than that in normal bone. In GCT, the ratio of ODF mRNA exceeded OPG expression. But in normal bone, the OPG mRNA exceeded ODF expression. Conclusions The results suggest that GCT contains all signals including OPG, ODF, M-CSF and RANK that are essential for inducing osteoclastogenesis and promoting bone resorption.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2002年第2期128-131,共4页 Chinese Journal of Pathology
基金 国家自然科学基金资助项目 ( 39830 430 )
关键词 骨巨细胞瘤 骨保护因子 破骨细胞 分化因子 骨质吸收 基因表达 mRNA Giant cell tumor of bone Tumor necrosis factor Bone resorption
  • 相关文献

参考文献22

  • 1Goldring SR, Roelke MS, Petrison KK, et al. Human giant cell tumors of the b o ne: identification and characterization of cell types. J Clin Invest,1987,79: 483-491.
  • 2赵宁侠,于世凤,庞淑珍,高岩.Ⅱ型碳酸酐酶在骨巨细胞瘤中的表达[J].中国骨质疏松杂志,1997,3(3):1-2. 被引量:4
  • 3赵宁侠,于世风,庞淑珍,高岩.空泡型质子泵在骨巨细胞瘤多核巨细胞中表达[J].中国骨质疏松杂志,1997,3(4):17-20. 被引量:2
  • 4赵宁侠,于世凤,庞淑珍.骨巨细胞瘤中的多核巨细胞体外骨吸收研究[J].北京医科大学学报,1998,30(5):429-432. 被引量:2
  • 5赵宁侠,于世凤,庞淑珍.IL-1α促进骨巨细胞瘤中破骨样细胞体外骨吸收研究[J].北京医科大学学报,1998,30(3):246-248. 被引量:4
  • 6Tsuda E, Goto M,Mochizuki S, et al. Isolation of a novel cyt okine from human f ibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Comm,1997,234: 137-142.
  • 7Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin(OPG) ligan d is a cytokine t hat regulates osteoclast differentiation and activation. Cell,1998,93: 165-176 .
  • 8Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand o f the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in Tcells. J Biol Chem,1997,272: 25190-25194.
  • 9Anderson MA, Maraskovsky E, Billingsley WL, et al. A homolog ue of the TNF rece ptor and its ligand enhence T-cell growth and dendritic-cell funtion. Nature ,1997,390: 175-179.
  • 10Quinn JM, Elliott J, Gillespie MT, et al. A combination of osteocla st differe ntiation factor and macrophage--colony stimulating factor is sufficient for bo th human and mouse osteoclast formation in vitro. Endocriology, 1998,139: 4424-4 427.

二级参考文献13

  • 1姜淑翠,钟慈声.囊泡膜质子泵的研究[J].生理科学进展,1993,24(2):164-167. 被引量:1
  • 2王延枝,许献忠.空泡膜类型H^+-ATPase的研究进展[J].生物化学与生物物理进展,1993,20(1):19-23. 被引量:18
  • 3赵宁侠,中国骨质疏松症杂志,1997年,3期,1页
  • 4赵宁侠,中国骨质疏松症杂志,1997年,3卷,4期,14页
  • 5Zhang W Z,Chin Med J,1994年,107卷,17页
  • 6史风琴,中华骨科杂志,1994年,14卷,435页
  • 7Zheng M H,Am J Pathol,1994年,145卷,1095页
  • 8Toysawa S,Virchows Arch Pathol,1991年,418卷,255页
  • 9Leu T C,Pathol Res Pract,1989年,185卷,448页
  • 10Zheng M H,Am J Pathol,1994年,145卷,5期,1095页

共引文献11

同被引文献30

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2王庆,蔡贤华,黄继锋.骨巨细胞瘤组织中Rb、c-erbB-2蛋白表达[J].中华实验外科杂志,2005,22(1):124-124. 被引量:4
  • 3张其亮,杨述华,吴翠环.骨巨细胞瘤中MMP-2的表达及其意义[J].江苏医药,2005,31(2):87-89. 被引量:2
  • 4华凯,李荣文,郭庆升,张世斌,吕刚,韩壮.p18蛋白在骨巨细胞瘤中表达的研究[J].中国矫形外科杂志,2005,13(12):927-928. 被引量:3
  • 5WULLING M, ENGELS C, JESSE N, et al. The nature of giant cell tumor of bone [ J]. J Cancer Res Clin Oncol, 2001,127:467-474.
  • 6YASUDA H, SHIMA N, NAKAGAWA N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhib- itory factor and is identical to TRANCE/RANKL [ J]. Proc Natl Acad Sci USA, 1998,95:3597-3602.
  • 7LACEY D L,TIMMS E,TAN H L,et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[ J]. Cell, 1998,93 : 165-176.
  • 8JOSIEN R, WONG B R, LI H L, et al. TRANCE, a TNF family member, is differentially expressed on T cells subsets and induces cytokine production in dendritic cells[J]. J Immunol, 1999, 162: 2562-2568.
  • 9ANDERSON D M, MARASKOVSKY E, BILLINGSLEY W L, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function[J]. Nature, 1997,390: 175-179.
  • 10SIMONET W S, LACEY D L, DUNSTAN C R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell, 1997,89:309-319.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部